Samplix wins €1.9 million in prestigious Horizon 2020 – SME Instrument program

Today, Samplix announced that the company has been selected by the European Commission among the winners of the prestigious Horizon 2020 – SME Instrument program, obtaining €1.9 million to mature its proprietary Xdrop™ technology. The selection process was highly competitive with more than 1.800 applicants and a success rate of only about 3%.

Samplix’ proprietary Xdrop™ technology comprises novel microfluidics, chemistry and bioinformatics in a simple work process that allows scientists and clinicians to partition millions of single molecules in droplets, thereby enabling both targeted enrichment and high-quality amplification of single molecules for sequencing analysis.

The Xdrop™ technology is currently in beta test at leading research institutions world-wide.

“We are excited to receive recognition and support by the European Commission for completion of our product development towards commercial launch of the Xdrop™ solution later this year” said CEO Lars Kongsbak.

Samplix business.png
< | >